Dear Reader,
Greetings from Germany, where we welcome the warmth and scent of the holiday season! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.
We welcome Prof. Dr. Hans de Vries as Senior Medical Scientist at Profil
| |
 |
We are proud to share with you that the world-leading expert in diabetes, Prof. Dr. de Vries, joined Profil to help us to further expand and strengthen our scientific capabilities. Read more.
|
|
|
|
The impacts of digitalization on diabetes treatment
|
 |
On our last online seminar this year, Prof. Lutz Heinemann talked about the advances of digitalization in diabetes and provided important insights into the future of diabetes treatment. If you missed it, you can watch our recorded online seminar.
|
|
|
|
The future for Hb1Ac
|
 |
Our Director Project Development, Dr. Eric Zijlstra, discussed the current position of HbA1c as the gold standard to evaluate the clinical efficacy of new anti-diabetes compounds and its future in clinical trials in an informative blog post.
|
|
|
|
Clinical trials in NAFLD using transient elastography
|
 |
Profil uses transient elastography for a non-invasive, painless and cost-effective staging of liver fibrosis and liver fat to support NAFLD early clinical trials. Are you interested in conducting a clinical trial addressing liver fibrosis or stiffness? Learn more about our capabilities.
|
|
|
|
Meet us at upcoming conferences
|
 |
Are you interested in knowing more about Profil? We attend all major conferences focused on diabetes, so if you are planning to go to any upcoming conference, we would love to schedule a meeting and tell you more about our expertise! |
|
|
We wish you a good week and look forward to the next "Profil World",
Tatiana Dicenzo - Scientific Communication Manager, Profil
|
|
